These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12360623

  • 1. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
    Svetyĭ LI, Pavlova LI, Mazerkina IA.
    Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
    [Abstract] [Full Text] [Related]

  • 2. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN.
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and hemodynamic effects of diltiazem in patients with arterial hypertension associated with ischemic heart disease].
    Bychko MV.
    Lik Sprava; 2007; (1-2):50-5. PubMed ID: 17682517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B.
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [Abstract] [Full Text] [Related]

  • 6. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG, Burmistrova LF, Berenshteĭn NV, Abramova GN, Lokhina TV, Shibaeva TM.
    Klin Med (Mosk); 2006 Oct; 84(11):52-6. PubMed ID: 17243612
    [Abstract] [Full Text] [Related]

  • 9. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A, Joire JE, Mounier-Vehier C, Lequeuche B.
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [Abstract] [Full Text] [Related]

  • 10. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Mar; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 11. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
    Martsevich SIu, Sementsov DP, Kutishenko NP, Alimova EV.
    Ter Arkh; 2001 Mar; 73(9):42-6. PubMed ID: 11642080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Assessment of time-dependent effects of long-acting altiazem in patients with hypertension stage II].
    Beliaev SD, Khetagurova LG, Zaslavskaia RM.
    Klin Med (Mosk); 2002 Mar; 80(3):62-6. PubMed ID: 11980164
    [Abstract] [Full Text] [Related]

  • 14. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 15. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term administration of diltiazem hydrochloride in hypertensive patients.
    Sawai K.
    Clin Ther; 1983 Jun; 5(4):422-35. PubMed ID: 6871924
    [Abstract] [Full Text] [Related]

  • 17. Diltiazem in the treatment of hypertension and ischemic heart disease.
    Barrios V.
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1375-82. PubMed ID: 22059786
    [Abstract] [Full Text] [Related]

  • 18. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary data on combined assessment of tolerance to exercise, left ventricular contractile function in ischemic heart disease patients taking bradycardic agents].
    Safonova EV, Zharova EA, Samoĭlenko LE, Sergienko VB.
    Ter Arkh; 2003 Jan; 75(4):29-33. PubMed ID: 12793133
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.